List of Studies ( Metabolite:Coenzyme Q6)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST003239 | AN005305 | Lipidomic analysis of adipose from Gclc WT and whole-body Gclc KO mice. | Adipose tissue | Mouse | Oxidative stress | University of Rochester Medical Center | Normalized to the median value of total lipid signals |
ST003240 | AN005307 | Lipidomic analysis of liver from Gclc WT and whole-body Gclc KO mice. | Liver | Mouse | Oxidative stress; Stress | University of Rochester Medical Center | Normalized to the median value of total lipid signals |
ST003241 | AN005309 | Lipidomic analysis of lung from Gclc WT and whole-body Gclc KO mice. | Lung | Mouse | Oxidative stress; Stress | University of Rochester Medical Center | Normalized to the median value of total lipid signals |
ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST002505 | AN004126 | A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) | Cultured cells | Human | Cancer | University of Science and Technology of China | Peak area |
ST003326 | AN005449 | Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism | Liver | Mouse | Liver disease | University of Melbourne | pmol/mg tissue |
ST002522 | AN004155 | Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice | Liver | Mouse | Oxidative stress | Department of Endocrinology and Laboratory for Diabetes, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China | Relative intensity |